Icon Bioscience's Convertible Note Round

Icon Bioscience raised a round of funding on December 03, 2015.

Icon Bioscience (IBI) is a privately held company focused on the development and commercialization of novel ophthalmic pharmaceuticals, based on its proprietary drug delivery platform, Verisome. IBI's…

Articles about Icon Bioscience's Convertible Note Round: